Lynk Solutec has been selected as a recipient of the SBA Bio-Medical Technology Commercialization Support Program, operated by the Seoul Business Agency (SBA). Details are as follows.
- Program: SBA Bio-Medical Technology Commercialization Support Program
- Supervising Authority: Seoul Business Agency (SBA)
- Project Title: Development of Innovative Medical Devices Applying Bio-Adhesion Prevention Coating (Lynk Coating)
- Selection Date: July 1, 2026
- Project Period: July 1, 2026 – June 30, 2028 (24 months)
- Funding
- Total Grant Amount: KRW 400,000,000
- Principal Institution: Lynk Solutec Co., Ltd.
- Project Scope
- Development and commercialization of innovative medical devices incorporating the company’s proprietary bio-adhesion prevention coating technology (Lynk Coating)
(END)
